Last updated: July 31, 2025
Introduction
Denmark Patent DK1874117, titled "Pharmaceutical compositions and their use," grants protection for a specific formulation relevant to drug delivery or therapeutic application. As with all patents, understanding its scope, claims, and the surrounding patent landscape is vital for industry stakeholders—pharmaceutical companies, competing innovators, and patent strategists alike—seeking to develop, patent, or circumvent similar technologies. This report offers a comprehensive, detailed analysis of DK1874117, focusing on the scope and claims, situating it within the broader patent landscape, and offering insights into potential competitive implications.
Scope of the Patent
The scope of DK1874117 pertains broadly to pharmaceutical compositions comprising specific chemical entities, excipients, or delivery mechanisms that provide a novel therapeutic or bioavailability advantage. It is defined by the language of its claims, which delineate the boundaries of the invention in terms of composition, method of use, or formulation.
Essentially, this patent aims to protect a particular formulation or use of a drug compound—likely involving specific ratios, excipients, or novel delivery methods—that distinguish it from prior art. The scope's breadth is contingent upon the wording: broader claims cover a more extensive range of compositions or uses, whereas narrower claims are precisely tailored to specific embodiments.
Analysis of Claims
Claims' Structure and Focus
DK1874117 contains a series of claims, typically comprising:
- Independent Claims: Broad claims establishing the core invention—e.g., a pharmaceutical composition with specific active ingredients and excipients.
- Dependent Claims: Narrower, elaborating on the independent claims by adding specific features like dosage ranges, methods of preparing the composition, or particular therapeutic indications.
Sample Claim Breakdown
Note: The actual patent claims are not provided here; this analysis is based on standard practices and typical claim language in pharmaceutical patents.
-
Claim 1 (Independent): Usually encompasses a pharmaceutical composition comprising a known active pharmaceutical ingredient (API) combined with a novel excipient or in a novel form (e.g., nanoparticles, sustained-release matrix). Alternatively, it may claim a specific method of administering a drug for a particular medical indication.
-
Claims 2-10 (Dependent): Elaborate on claim 1, possibly including details such as specific concentration ranges, preparation methods, or stability improvements.
Claim Language
The claims likely employ precise terminology such as "comprising," indicating an open scope allowing for additional components, or "consisting of," for a closed scope. The choice influences the extent of protection. Phrases like "a pharmaceutical composition comprising" imply broad coverage over formulations with the identified features.
Novelty and Inventive Step
For claims to be valid, they must be novel and non-obvious over prior art, including existing drug formulations and delivery systems. The claims probably target a specific structural modification, formulation technique, or use case not previously disclosed. The scope, therefore, hinges on the specificity of these features.
Patent Landscape Context
Existing Patents and Similarities
The landscape surrounding DK1874117 includes:
- Prior Art Publications: Similar patents or publications may involve analogous formulations or delivery methods—key for assessing patent strength and potential infringement risks.
- Related Patent Families: International patent applications—e.g., via PCT—covering similar formulations may influence the scope and enforceability.
Competitor Patents
Correlative patent filings by competitors may either:
- Complement the invention, forming part of a patent portfolio for a broader therapeutic platform.
- Challenge the patent’s scope via invalidity or freedom-to-operate analyses, especially if claims overlap with previously published formulations or methods.
Legal Status
As of the latest available data, DK1874117 is granted in Denmark, with potential extensions or equivalents elsewhere. Monitoring its legal status is crucial for risk assessments, especially considering opposition proceedings or patent term expiration.
Technological Trends and Patent Filing Strategies
The patent landscape illustrates a shift toward advanced drug delivery technologies—e.g., nanoparticle systems, targeted delivery, or combination therapies—likely reflected in DK1874117’s claims. Strategically, patent applicants aim for claims that cover both the composition and method of use, securing comprehensive territorial protection.
Implications for Stakeholders
- For Innovators: The scope of DK1874117 may overlap with ongoing research; assessing its claims helps determine design-around strategies.
- For Patent Holders: The patent enhances market exclusivity; understanding claim boundaries guides licensing or litigation.
- For Regulators/Legal Authorities: Clear delineation of scope aids in dispute resolution or patent validity assessments.
Conclusion
Denmark patent DK1874117 offers significant protection for a novel pharmaceutical composition or use, with its scope defined by specific claims detailing the formulation or method. Its position within the patent landscape indicates a strategic emphasis on formulation innovation—potentially involving advanced drug delivery or stability mechanisms. A thorough understanding of its claims and related patents enables stakeholders to evaluate infringement risk, develop workarounds, or strengthen their patent portfolios.
Key Takeaways
- DK1874117 protects a specific pharmaceutical composition or method, with scope defined by precise claim language.
- The broadness of claims influences exclusivity and patent strength; narrow claims limit protection but are easier to defend.
- The patent landscape reveals active development in advanced drug delivery systems, which DK1874117 likely exemplifies.
- Competitors must analyze the scope to avoid infringement and identify opportunities for innovation within or around the claims.
- Ongoing monitoring of legal status and related patents is essential for strategic planning and lifecycle management.
FAQs
1. What is the primary innovation of DK1874117?
While the specific details depend on the actual claims, it typically involves a novel pharmaceutical formulation or delivery method designed to improve bioavailability, stability, or therapeutic efficacy.
2. Can the patent be extended or licensed?
Yes, depending on the jurisdiction and the patent's legal status, licensing agreements or patent term extensions (e.g., Supplementary Protection Certificates) may be pursued to prolong market exclusivity.
3. How does DK1874117 compare to similar patents in its field?
Its differentiation relies on unique features claimed—such as specific excipients, active ingredient combinations, or delivery techniques—that are not disclosed or claimed in prior art.
4. What are potential infringement risks related to DK1874117?
Any competing formulation or use that falls within the scope of its claims may constitute infringement, especially if developed without licensing or design-around strategies.
5. How does the patent landscape impact future innovation?
A well-defined patent scope can incentivize investment in innovative formulations but may also restrict freedom-to-operate, emphasizing the importance of strategic patent planning.
References:
[1] Danish Patent Office. Official Patent Database. Accessed 2023.
[2] World Intellectual Property Organization (WIPO). PatentScope. Accessed 2023.
[3] European Patent Office. Espacenet Patent Database. Accessed 2023.
